NurExone signs binding MOU with Made Scientific for exclusive US GMP exosome manufacturing partnership

Reuters2026/08/12 21:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NurExone Biologic signed a binding MOU with Made Scientific for an exclusive U.S. GMP manufacturing partnership for bone marrow-derived exosomes.
Made Scientific to handle U.S. manufacturing, aseptic fill-finish, commercial exosome supply to support clinical development.
Technology transfer to start immediately; first GMP exosome batches targeted for H1 2027.
MOU contemplates a 5-year term with 5-year renewal options; exclusivity ends if no definitive deal within six months.
Company dropped its earlier non-binding LOI with BioXtek as it consolidates U.S. GMP manufacturing under Made Scientific.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NurExone Biologic Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608121702PRIMZONEFULLFEED9809058) on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NurExone signs binding MOU with Made Scientific for exclusive US GMP exosome manufacturing partnership

You may also like

Crypto prices